Boehringer Ingelheim, HealthPrize team on Spiriva Respimat support program

RIDGEFIELD, Conn. — Boehringer Ingelheim on Wednesday announced a new online program for patients treating their COPD with the company’s Spiriva Respimat. The program, RespiPoints, is being undertaken in partnership with HealthPrize Technologies. 

 

RespiPpoints provides tools to patients to help improve healthy behaviours, encourage healthy habits and track medication adherence. Enrolled patients can earn points that can be redeemed for e-gift cards through such activities as reporting they took their daily Spiriva Respimat dose, verifying their monthly refill, reading educational materials about COPD and completing weekly quizzes and surveys. 

 

“Boehringer Ingelheim is committed to providing support and resources for patients’ needs beyond our industry-leading six COPD medicines,” Boehringer Ingelheim executive director and head of business innovation Ruchin Kansal said. “We are proud to continue our unwavering commitment to the COPD community with new technology and support services that can help improve patient outcomes. The RespiPoints program is the latest in a series of efforts to empower people living with COPD to better manage their health with tools that are engaging and educational”